[July 29, 2016] |
|
DNA Polymerase Beta Inhibitors Market Report - Pipeline Insights 2016 - Research and Markets
Research and Markets has announced the addition of the "DNA
Polymerase Beta Inhibitors - Pipeline Insights, 2016" report to
their offering.
DNA Polymerase Beta Inhibitors - Pipeline Insights, 2016 provides in
depth insights on the pipeline drugs and their development activities
around the DNA Polymerase Beta Inhibitors. The report covers the product
profiles in various stages of development including Discovery,
Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for DNA Polymerase
Beta Inhibitors.
The report also assesses the DNA Polymerase Beta Inhibitors therapeutics
by Monotherapy, Combination products, molecule type and Route of
Administration.
Scope
-
The report provides compettive pipeline landscape of DNA Polymerase
Beta Inhibitors
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the DNA Polymerase Beta Inhibitors pipeline on the basis
of target, MOA, route of administration, technology involved and
molecule type
-
The report reviews key players involved in the therapeutics
development for DNA Polymerase Beta Inhibitors and also provide
company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/s5qp7m/dna_polymerase
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005789/en/
[ Back To TMCnet.com's Homepage ]
|